MMC BioBank receives accreditation from College of American Pathologists (CAP)
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to the Maine Medical Center BioBank based on results of a recent on-site inspection. The BioBank Director, Anne C. Breggia, Ph.D., was advised of this national recognition on Dec 24, 2014 and congratulated for the excellence of the services being provided. The MMC BioBank is one of only 30 accredited biorepositories nationwide.
“In the age of personalized medicine, biorepositories serve as vital resources for clinical and translational research leading to novel therapies and improved patient outcomes", explains Dr. Breggia
Through the CAP accreditation, the MMC BioBank demonstrates to the scientific community that the BioBank processes for collection, processing and storage of biospecimens follow the highest standards. CAP Biorepository accreditation is quickly becoming the standard used by investigators when choosing a source of biospecimens for their research. Through the CAP accreditation, the MMC BioBank staff has demonstrated their dedication and commitment to the research and patient care missions of MMC.
About the MMC BioBank
The MMC BioBank was created 12 years ago by Michael Jones, MD, Chief of Pathology at MMC, whose vision was to create a source of human biospecimens that could be used by MMC clinicians and scientists for biomedical research. In 2012, the BioBank became a core facility of Maine Medical Center Research Institute (MMCRI) with Anne C. Breggia, PhD., appointed as the Research Program Director. Dr Jones and Dr. Breggia work in close partnership to maintain the excellence and expand the services of the MMC BioBank.
The MMC BioBank has more than 150,000 tissue samples available for research collected primarily from cancer and inflammatory disease surgeries and obtained under an IRB approved protocol using patient informed consent. The BioBank supplies biospecimens to support the research of MMC and MMCRI physicians and scientists and assists in the collection and distribution of tissue for three of the National Cancer Institute’s (NCI) Cooperative Cancer Groups: Children’s Oncology Group (COG), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG). The BioBank also provides tissue to the Jackson Laboratories Xenograft project, which creates mouse models of cancer for the investigation of novel cancer therapies. In 2013 the BioBank became a tissue resource for The Cancer Genome Atlas (TCGA) project, a national project funded by the NIH that seeks a comprehensive understanding of the genetics of cancer. The BioBank is a member of the International Society of Biological and Environmental Repositories (ISBER).
The MMC BioBank is one of two in the Northeast to achieve CAP Accreditation. The Tufts Biorepository in Boston, MA was CAP Accredited in 2012. Other leading academic medical centers to be CAP Accredited include St Jude’s Children’s Research Hospital, Rutgers University, UCLA, Johns Hopkins and Duke University. More information about the MMC BioBank can be found at www.mmcri.org.
About the College of American Pathologists
The College of American Pathologists (CAP), the gold standard in laboratory accreditation for over 50 years, has accredited 176,000 clinical pathology laboratories in 50 countries and serves more than 18,000 physician members. It is the world’s largest association composed exclusively of board certified pathologists and is the worldwide leader in laboratory quality assurance. CAP advocates accountable, high quality and cost effective patient care. More information about CAP can be found at www.cap.org.
The CAP Accreditation for biorepositories was first offered in 2012. Since then, CAP has received 54 applications and 30 biorepositories have been accredited. Of these, 9 are commercial biorepositories and twenty-one are Academic or Medical Center based.